Patients

cleanroom.jpgDendritic Cell (DC) therapy represents a promising immunotherapeutic approach for the treatment of cancer. The beauty of DC therapy is that it exploits the body's own immune system to fight cancer. Since 1997 we perform clinical trials to test the potency of this approach. For each patient a specialized vaccine is prepared from immune cells isolated from the blood. In specialized cleanrooms, a personalized DC vaccine is prepared after which patients are vaccinated. For more details on the DC vaccination procedure see this movie. So far, our clinical trials are mainly focused on melanoma, a cancer of the pigmented cells of the skin. We have treated more than 350 patients until now and observed that DC vaccination is well tolerated with minimal side effects. If you are interested in further information, Dutch patients can consult the Dutch www site. Of course you can always consult your physician.